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Abstract
Introduction: Many different prosthetic materials have been used for repair of large posterolateral
congenital diaphragmatic hernias, which cannot be primarily repaired. Almost 50% of patch repaired
diaphragmatic hernias will recur. The ideal prosthetic material for congenital diaphragmatic hernia
repair has yet to be established. We report on two cases with unusual (calcification) and late
complications related to the prosthetic material used for diaphragmatic hernia repair.
Case presentation: We report two cases of antenatally diagnosed left-sided diaphragmatic hernia
that were repaired with a patch due to total absence of a diaphragm. Both Caucasian patients
developed recurrent late graft complications. Case one was repaired on day 17 post-stabilisation and
developed recurrence at 14½ months of age and again at 26 months of age. Case 2 underwent
surgery on day 13 of life and developed recurrence at 4 months and again at 3 years of age. In the
recurrent repairs, both synthetic and biomaterial patches were used. Both patients are well at long-
term follow-up of 10 and 7 years, respectively.
Conclusion: The ideal choice of patch material for diaphragmatic hernia repair remains a
therapeutic challenge.
Introduction
Congenital diaphragmatic hernias (CDH) occur with an
estimated incidence of 1/2-4000 live births [1] and almost
invariably require surgical intervention. The majority of
defects are left-sided and sufficiently small to permit
primary closure. Larger defects or total agenesis require
closure with a prosthetic patch or flap, the latter usually for
recurrent hernias. The patch material used may be the
major contributing modifiable factor determining the
incidence of late complications well after the time of
surgery.
Case presentation
Case report 1
A full-term Caucasian female neonate with antenatally
diagnosed left-sided CDH underwent surgical repair of a
large defect at 17 days with Gore-Tex (expanded poly-
tetrafluoroethene (PTFE); WL Gore & Associates Inc). One
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gastrostomy aged 14½ months, she presented with a
recurrence through a ~2 cm anteromedial dehiscence of
the patch. The defect was later closed primarily via
thoracotomy and the hemidiaphragm reinforced with
Surgisis (porcine small intestine submucosa (SIS) col-
lagen; Cook Inc). At 26 months of age, the child presented
with an abscess at the site of the previous thoracotomy and
computed tomography demonstrated an intrathoracic
collection associated with the prostheses (Figure 1). After
initial drainage of the external component, at thoracotomy
both collections were found to be in continuity and the
distorted Gore-Tex patch within the abscess cavity was
excised. There was sufficient fibrous ‘neodiaphragm’ to
permit primary closure of the defect with no need for a
further patch. To date, at 10 years of age there have been
no further recurrences or complications.
Case report 2
A full-term male Caucasian neonate with antenatally
diagnosed left-sided CDH underwent surgical repair of a
large defect on day 13 of life with a Permacol patch
(porcine dermal collagen; Tissue Science Laboratories). A
posterior recurrence was noted at 4 months of age and a
posterolateral defect at the edge of the previous repair was
closed with a Gore-Tex patch. At laparotomy, through the
original subcostal incision, the Permacol derived tissue
was noted to be fibrotic and calcified. Acute on chronic
respiratory compromise heralded a further recurrence at
3 years of age confirmed by contrast enema. At lapar-
otomy, the Gore-Tex patch was intact with little evidence
of any residual Permacol and only a small anterior rim of
diaphragm representing the original native tissue. The
Gore-Tex patch was excised and the entire defect repaired
with Surgisis. To date, at 7 years of age there have been no
further recurrences or complications.
Discussion
The repair of CDH has evolved over recent years with the
development of patches composed of biomaterials
reported to better integrate with host tissues and,
eventually being replaced by them. The recent literature
reports patch repair of CDH in up to 50% of cases [2] in
contrast to earlier series where patch repair was less
common [3] and may represent earlier referral and surgical
intervention. These two cases highlight the problems
related to the use of patches for CDH repair in individual
patients.
Where primary closure is not possible, the goal of the
repair isto provide amechanically robust pleuroperitoneal
partition that will endure for the patient’s lifetime,
potentially to normal life expectancy. As demonstrated
in both cases, synthetic patch integrity is usually main-
tained during recurrence which largely occurs due to
failure at the host-prosthesis interface. In contrast, failure
of flap or biomaterial patch repair in the absence of
infection (Case 2) occurs by patch failure, probably due to
a combination of inadequate angiogenesis, host tissue in-
growth and deterioration of the patch/flap due to atrophy
or the inflammatory response.
Gore-Tex patches surpassed several similar materials in
terms of clinical utility and there is good general surgical
experience with their use in a variety of applications.
Although durable and promoting a degree of angiogenesis,
they remain in situ for life and are a potential site of
microbial colonisation. There are usually few options
following patch infection other than excision (Case 1) and
in a recent series, 41% required revision within 3 years [4].
The two biomaterials used in these cases are collagen
scaffolds derived from porcine tissue and marketed as
acellular materials that are assimilated and eventually
replaced by host tissue. Although collagen biomaterials
meet European Union/Federal Drug Administration man-
ufacturing and processing regulations, their acellularity
has been questioned and the potential for zoonotic
infections remains. Laboratory comparison of collagen-
based and synthetic patches has produced inconsistent
findings thatare difficult to compare due to thediversity of
experimental models utilised and combinations of mate-
rials studied. The former are generally found to produce
Figure 1. Computed tomography demonstrating an abscess
associated with a distorted radio-opaque Gore-Tex patch.
S. pneumoniae was isolated from the contents.
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greater inflammatory response with greater potential for
adhesion formation. The reported mechanical properties
are inconsistent [5].
This is the first time we have encountered calcification of a
Permacol graft (Case 2) which may have reduced patch
flexibility and contributed to the recurrence. Experimental
evaluation of SIS derived collagen has shown that
glutaraldehyde cross-linking promotes calcification, poor
host-tissue incorporation and ultimately mechanical fail-
ure compared to peracetic acid treated and native SIS [6].
Perhaps significantly, commercially available Permacol is
cross-linked whereas, currently, Surgisis is supplied in its
native form. Problematic fibrotic reactions (orbital and
urological surgery) and several instances of graft failure in
orthopaedic applications have been reported but there is
no systematic or comprehensive reporting of complica-
tions either in the literature or by the manufacturers.
Experimental subcutaneous implantation [5,6] assesses a
microenvironment more conducive to the angiogenesis
necessary for successful assimilation in contrast to inher-
ently less well vascularised joint spaces and the diaphragm
where,intheabsenceofadhesions,host-tissuein-growthis
limited to the patch periphery. Direct comparison of the
angiogenic potential of various materials is hampered by
difficulty in determining the proportion of the observed
increase in vascularity due to angiogenesis and that due to
the inflammatory response [5].
We experienced no early failure following use of Surgisis
and in Case 1, the development of a fibrous membrane
permitted primary closure without a further patch. Small
series of successful use of Surgisis in diaphragmatic hernia
repair have been reported [7] but not all cases are
neonates/infants and mortality rates are high in such
small groups.
Use of local muscle flaps (intercostals [8], reversed
lentissimo dorsi [9]) for CDH repair has been reported
but they produce significant body wall deformity and are
largely restricted to recurrent CDH. Although the risk of
infection is greatly reduced, denervated muscle tissue
tends to atrophy predisposing it to further recurrence and
attempts at microneural anastomosis have produced
equivocal outcomes [9]. Lack of long-term follow-up and
reluctance to publish ineffective approaches make evalua-
tion difficult. Application of a non-deforming intraper-
itoneal (Toldt’s) fascial flap has recently been reported but
again it is too early to evaluate long-term outcomes [10].
Conclusions
The literature presents series of variable size and clinical
consistency but fails to provide a robust evidence base on
which graft materials can be selected or approaches to
CHD repair chosen with regard to long-term outcome.
Recurrence produces major morbidity and thetrue lifetime
incidence is not known. The medical literature lags behind
the rapid development and modification of prosthetic
materials and it is hoped that this situation will change in
the near future.
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